http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2455966-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6379feda6e2eb9af0653088fc5870448
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
filingDate 2011-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2012-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69ec46f76dca0029ed4f6783bfa3687b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50aaf047cb3f0d481b143e21ad72b9b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a419fe482176e81be127d39a9db84118
publicationDate 2012-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2455966-C1
titleOfInvention Method of microinvasive surgical treatment of retinal detachment recurrence
abstract FIELD: medicine. n SUBSTANCE: invention relates to medicine, in particular to ophthalmology and can be used in surgical treatment of retinal detachment recurrence at the background of tamponade with light silicone oil (LSO) with density 0.97 g/cm 3 . Microinvasive suture-free access into vitreous cavity is performed at the background of tamponade with LSO. LSO is removed, epiretinal membranes and remnants of vitreous body are contrasted with methylene blue solution, after which complete ablation of vitreous body remnants, epiretinal and subretinal membranes is performed by carrying out dosed lower retinotomy. Vitreous cavity is filled in with gas SF 6, endolaser coagulation of retina is performed at the background of gas tamponade, PFOC is introduced, re-tamponade is performed by single-stage substitution of PFOC with FSO. n EFFECT: method makes it possible to ensure complete mobilisation, adaptation and fixation of retina, achieve maximally high visual functions in post-operative period n 1 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2635452-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2548814-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2791413-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2644296-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2787155-C1
priorityDate 2011-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2405506-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74483
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419476681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4139
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526573

Total number of triples: 23.